These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8982406)

  • 1. Plasma endothelin in psoriasis: possible relations to therapy and toxicity.
    Zachariae H; Heickendorff L; Bjerring P
    Acta Derm Venereol; 1996 Nov; 76(6):442-3. PubMed ID: 8982406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional therapies for psoriasis.
    Rebora A
    Reumatismo; 2007; 59 Suppl 1():77-80. PubMed ID: 17828351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D and systemic therapy.
    van de Kerkhof P
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current systemic therapies for psoriasis: where are we now?
    Yamauchi PS; Rizk D; Kormeili T; Patnaik R; Lowe NJ
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S66-77. PubMed ID: 12894129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative tolerability of systemic treatments for plaque-type psoriasis.
    McClure SL; Valentine J; Gordon KB
    Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future oral systemic therapies for psoriasis.
    Kelly JB; Foley P; Strober BE
    Dermatol Clin; 2015 Jan; 33(1):91-109. PubMed ID: 25412786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
    Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
    Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
    [No Abstract]   [Full Text] [Related]  

  • 8. Acitretin combination therapy.
    Roenigk HH
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S18-21. PubMed ID: 10459142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
    Short MW; Vaughan TK
    Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional systemic agents for psoriasis. A systematic review.
    Strober BE; Siu K; Menon K
    J Rheumatol; 2006 Jul; 33(7):1442-6. PubMed ID: 16724368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verrucous psoriasis treated with methotrexate and acitretin combination therapy.
    Shivers L; Montanez-Wiscovich ME
    Cutis; 2019 Dec; 104(6):E10-E12. PubMed ID: 31939936
    [No Abstract]   [Full Text] [Related]  

  • 13. New guidelines for managing psoriasis with systemic medications.
    Dermatol Nurs; 2009; 21(5):301-3. PubMed ID: 19873700
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic therapy of psoriasis].
    Altmeyer P; Nüchel C
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing.
    Feldman SR; Nijsten T; Margolis DJ; Rolstad T
    J Am Acad Dermatol; 2005 Jan; 52(1):140-1. PubMed ID: 15627096
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of treatment with methotrexate and coal tar on adipokine levels and indices of insulin resistance and sensitivity in patients with psoriasis vulgaris.
    Rajappa M; Rathika S; Munisamy M; Chandrashekar L; Thappa DM
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):69-76. PubMed ID: 24665910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
    Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
    J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic therapy in the treatment of psoriasis: drugs of prebiological era].
    Kurilić M; Prpić-Massari L; Brajac I; Kastelan M
    Lijec Vjesn; 2010; 132(7-8):246-51. PubMed ID: 20857811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.